Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/1996
03/28/1996WO1996009050A1 Methods of inhibiting endometrial mitoses
03/28/1996WO1996009038A2 Alteration of activity and/or levels of haem-oxygenase to control inflammation
03/28/1996CA2200451A1 Methods of inhibiting endometrial mitoses
03/27/1996EP0703218A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
03/27/1996EP0702681A1 Spiro-substituted azacycles as neurokinin antagonists
03/27/1996EP0702672A1 New active compounds
03/27/1996EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions
03/27/1996CN1119440A 2,6-diaminopurine derivatives
03/27/1996CN1119187A oxalylamino-benzofuran- and benzothienyl-derivatives
03/27/1996CN1119101A Thieno (1,5) benzodiazepine use
03/27/1996CN1031404C Process for production of substituted azole
03/27/1996CA2159034A1 Method of minimizing hepatic reperfusion injury
03/26/1996US5502209 Benzopyrancarboxamide derivatives, salts thereof, process for the preparation of same and use thereof
03/26/1996US5502077 Fatty acid composition
03/26/1996US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents
03/26/1996US5502059 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
03/26/1996US5501861 Carbohydrates
03/23/1996CA2132690A1 Control and modulation of inflammatory response in humans in need of such control and modulation
03/21/1996WO1996008493A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008492A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008480A1 Neurokinin antagonists
03/21/1996WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/21/1996WO1996008269A1 Inhibition of human rotavirus infection
03/21/1996WO1996008247A1 Anti-helicobacter agent
03/21/1996WO1996008238A1 Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
03/21/1996CA2200083A1 Neurokinin antagonists
03/21/1996CA2200056A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2200055A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2199707A1 Inhibition of human rotavirus infection
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0701988A1 Substituted cyclopentane-di- and triones, their preparation and their use as chloride channel blockers
03/20/1996EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701565A1 New prednisolone derivates
03/20/1996CN1119014A Benzopyranes as potassium channel openers
03/20/1996CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines
03/20/1996CN1118782A Cyclohexan-derivative, preparation and application for treatment of same
03/20/1996CN1118766A A hexagonal molecular structure water manufacturing apparatus and a method thereof
03/19/1996US5500430 Amidic derivatives of glutamic, aspartic and 2-amino adipic acids, a process for preparing same, and anti-gastrin composition containing the derivatives
03/19/1996US5500421 Liver disorders
03/17/1996CA2158222A1 Use of substituted cyclopentane- di- and triones
03/14/1996WO1996007915A1 Predictive test for hepatitis-b resistance
03/14/1996WO1996007649A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996CA2198707A1 Predictive test for hepatitis-b resistance
03/14/1996CA2198477A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/13/1996EP0700905A1 Tricyclic pyrazole derivatives
03/13/1996EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700398A1 Psoralen derivatives, their preparation and use as medicaments
03/13/1996EP0700396A1 Piperidine derivatives, their preparation and use
03/13/1996EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
03/13/1996EP0700301A1 Peptides and compounds that bind to elam-1
03/13/1996EP0700292A1 Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
03/13/1996EP0700290A1 Rectal compositions
03/13/1996EP0700283A1 Liquid antacid compositions
03/13/1996EP0665746A4 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF-g(a)PE 40?ab.
03/13/1996EP0540613B1 Products and processes for the treatment of the alimentary canal
03/13/1996EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
03/13/1996EP0514527B1 Chlorinated eta alumina-based catalyst and its use in isomerisation of c4-c6 n-paraffins
03/13/1996EP0506817B1 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
03/13/1996EP0472588B1 Use of alpha-d-galactosidase for the preparation of a pharmaceutical composition for reducing gastro-intestinal distress due to alpha-d-galactoside-linked sugars.
03/13/1996EP0439513B1 Composition for inhibiting transmission of aids
03/13/1996CN1118571A Bisacodyl dosage form
03/13/1996CA2157998A1 Pharmaceutical compounds
03/12/1996US5498699 Complexes and chelates of azithromycin with bivalent and/or trivalent metals and their use as antiulcer
03/12/1996US5498623 4(5) substituted imidazoles and their preparation and use
03/12/1996CA2016182C Heterocyclicguanidines as 5ht- antagonists
03/07/1996WO1996006861A1 Trefoil peptide dimer
03/07/1996WO1996006842A1 Salts of an anti-migraine indole derivative
03/07/1996WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006620A2 Lipid analogs for treating viral infections
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/06/1996EP0699689A1 Branched polysaccharide, microorganism producing it and compositions containing them
03/06/1996EP0699678A1 Crystalline form of dihydro-2,3-benzodiazepine derivative
03/06/1996EP0699676A1 Physical form of dihidro-2,3-benzodiazepine derivative
03/06/1996EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists
03/06/1996EP0699665A1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists
03/06/1996EP0699444A2 Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat
03/06/1996EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
03/06/1996EP0699199A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
03/06/1996EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/06/1996EP0587723B1 Quinuclidine derivatives
03/06/1996CN1117874A Nasally administrable compositions
03/06/1996CN1031193C Polypeptide and method for preparing same
03/05/1996US5496828 Methods of inhibiting ulcerative mucositis
03/05/1996US5496558 Solid form xerostomia product
03/01/1996CA2157240A1 Pharmaceutical formulation of nizatidine
02/1996
02/29/1996WO1996006074A1 Metalloproteinase inhibitors
02/29/1996WO1996005843A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol
02/29/1996WO1996005838A2 Combined preparation for the therapy of immune diseases
02/29/1996WO1996005837A1 Use of n-substituted phenothiazines
02/29/1996WO1996005831A1 Methods of inhibiting ulcerative mucositis
02/29/1996WO1996005829A1 Methods of maintaining teeth and oral bone
02/29/1996WO1996005828A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 1258